Company Description
Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally.
The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services.
It also offers regulatory support, including handling communications with the food and drug administration (FDA) and seek consultation and guidance for client FDA meetings and responses; and pharmaceutical packaging and logistics, as well as smaller-scale primary and secondary packaging, labeling and kitting options suited for clinical trial materials and development packaging needs across dosage forms.
The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022.
Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
| Country | United States |
| Founded | 2007 |
| IPO Date | Mar 7, 2014 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 258 |
| CEO | J. David Enloe Jr. |
Contact Details
Address: 1 E. Uwchlan Ave, Suite 112 Exton, Pennsylvania 19341 United States | |
| Phone | 770-534-8239 |
| Website | societalcdmo.com |
Stock Details
| Ticker Symbol | SCTL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001588972 |
| CUSIP Number | 75629F109 |
| ISIN Number | US75629F1093 |
| Employer ID | 26-1523233 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Wayne B. Weisman J.D. | Executive Chairman of the Board |
| J. David Enloe Jr. | President, Chief Executive Officer and Director |
| Ryan D. Lake CPA | Senior Vice President and Chief Financial Officer |
| Marshall Rizzo M.B.A. | Senior Vice President and Chief Operating Officer |
| Richard Sidwell Ph.D. | Senior Vice President and Chief Scientific Officer |
| Cristin Grove | Vice President of Sales |
| Erica Raether M.A. | Senior Vice President and Chief People Officer |